-
(2E)-3-(1-methyl-1H-pyrazol-5-yl)-2-Propenoic acid ethyl ester
-
AKOS B017627
-
(R)-(-)-3-bromo-2-methyl-1-propanol
-
4-Chloro-7-methoxyquinoline-6-carboxamide
-
7-Bromoindoline
-
(2R,4S)-5-([1,1’-biphenyl]-4-yl)-4-amino-2-methylpentanoic acid hydrochloride
-
Beta-Methyl vinyl phosphate (MAP)
-
4-Bromonicotinic acid
-
1,4-Dibromo-2,3-bis(bromomethyl)-2-butene
-
[(4S)-4-Hydroxynonyl]phosphonic acid dimethyl ester
-
N,N-diphenylimidazole-1-carboxamide
-
(R)-1,4-Benzodioxane-2-carboxylic acid
-
OPC 13015
-
2-bromo-5-fluorothiazole
-
4-Bromo-1-(4-nitrobenzoyl)-1,2,3,4-tetrahydro-5H-1-benzazepin-5-o ne
-
Tetraethylammonium fluoride hydrate
![(2R,4S)-5-([1,1’-biphenyl]-4-yl)-4-amino-2-methylpentanoic acid hydrochloride](https://stcdn.activebiopharma.com/active/ABP026749.png)
![[(4S)-4-Hydroxynonyl]phosphonic acid dimethyl ester](https://stcdn.activebiopharma.com/active/ABP026745.png)
Copyright © 2015-2025 Active Biopharma Corp. All rights reserved. Support by Moldb.
浙公网安备 33010802003999号